Lawrence Corey, Professor of Laboratory Medicine, Microbiology, and Medicine, University of Washington


Raphael Dolin, Head, Infectious Diseases Unit, University of Rochester School of Medicine and Dentistry




The Philosophy of Drug Regulation in the United States: Is It Changing from Beneficence to Patient Autonomy?



Dan Brock, Professor of Philosophy, Brown University



Harold Edgar, Professor of Law, Columbia University School of Law

Bernard Lo, Director, Program in Medical Ethics, University of California

Daniel Wikler, Professor, Department of Philosophy, University of Wisconsin

Carol Levine, Executive Director, Citizens Commission on AIDS




Issues of Cost and Coverage: How Will the Changes Affect the Drug Industry, Payers, and Patients?



Patrick Gage, Executive Vice President, Genetics Institute, Inc.



Jerome Birnbaum, Executive Vice President for Research, Bristol-Myers Squibb Company

Paul De Stefano, Chief Corporate Counsel, Genentech, Inc.

David Higbee, Branch Chief, Catastrophic Medical Services, Office of Coverage Policy, Health Care Financing Administration

Susan Gleeson, Executive Director, Technology Management, Blue Cross and Blue Shield Association

Steven Peskin, Vice President and Medical Director, CIGNA Healthplan of Texas, Inc.

The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement